Share Prices & Company Research

Stockbroking

Futura Medical

Current Price 32.78p Bid 32.00p Ask 33.00p Change 0.00%
Last Updated: 15/11/2019 05:19. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Futura Medical plc is a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys drug delivery technology. These products are optimised for clinical efficacy, safety, administration and patient convenience and are developed for the prescription and consumer healthcare markets as appropriate. Current therapeutic areas are sexual health, including erectile dysfunction, and pain relief. Development and commercialisation strategies are designed to maximise product differentiation and value creation whilst minimising risk.

Financial Highlights Year Ended 31/12/2018

Turnover
£0.00m
Operating Profit
£-7.27m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-6.78

Key Personnel

James Henry Barder
Chief Executive Officer
Kenneth William James
Executive Director
Angela Hildreth
Finance Director
John Milne Clarke
Non-Executive Chairman
Jonathan David Freeman
Non-Executive Director

Stock Details

EPIC
FUM
ISIN
GB0033278473
Shares in Issue
204,660,267
Market cap
£61.91m

Analyst Views (1)

Strong Buy
 
100.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
0.00p
Bid Price
32.00p
Ask Price
33.00p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
0.00p
Previous Close
32.50p
Intraday High
0.00p
Intraday Low
0.00p
52 Week High
48.25p
52 Week Low
5.61p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Futura Medical Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Tangible Assets
0.1
0.1
Intangible Assets & Goodwill
0.0
0.0
Investments & Other Non-Current Assets
0.0
0.0
Total Non-Current Assets
0.1
0.1
Inventory
0.0
0.1
Trade & Receivables
0.3
0.2
Cash & Receivables
9.2
8.4
Other Current Assets & Assets Held for Resale
1.4
0.9
Total Assets
10.9
9.6

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Short Term Liabilities
2.0
0.5
Long Term Liabilities
0.0
0.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
2.0
0.5

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Net Assets
8.9
9.1

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Share Capital
0.4
0.2
Minority Interests
0.0
0.0
Retained Earnings
-42.7
-37.0
Share Premium Account
50.0
44.7
Other Equity
1.2
1.2
Total Equity
8.9
9.1

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Cashflow from Operating Activities
-4.7
-4.2
Cashflow Before Financing
-4.7
-4.2
Increase / Decrease in Cash
0.8
-4.0

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Turnover
0.0
0.4
Cost of Sales
0.0
0.0
Gross Profit
0.0
0.0
Operating Profit
-7.3
-4.9
Pre-Tax Profit
-7.2
-4.8
Profit / Loss for the Year
-5.9
-3.9
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.